Image

Global Incretin Mimetics Market – Industry Trends and Forecast to 2029

Pharmaceutical

Image

Global Incretin Mimetics Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Incretin Mimetics Market, By Indication (Diabetes, Others), Drugs (Exenatide, Liraglutide, Sitagliptin, Saxagliptin, Alogliptin, Linagliptin, Others), Route of Administration (Oral, parenteral, Others), Application (Solid Tumors, Blood-related Tumor), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Incretin Mimetics Market

Incretin Mimetics Market Analysis and Size

The global incretin mimetics market is expected to witness significant growth during the forecast period. Growing cases of type 2 diabetes mellitus drive the incretin mimetics market. Due to increased inherited disorder & adaptation of unhealthy lifestyle, which causes type 2 diabetes also boost up the incretin mimetics market growth.  The major market players in the neuraminidase inhibitors market are focusing on launching new drugs in the market, which is expected to grow in the market in the forecast period. COVID-19 also had a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the global incretin mimetics market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Incretin mimetics are the agents are used to treat type 2 diabetes. They act like incretin hormones such as GLP-1 (glucagon-like peptide-1). They bind to the GLP-1 receptors and stimulate glucose dependent insulin release, therefore acting like antidiabetic agents. Incretin mimetics also inhibit glucagon secretion, suppress appetite, slow gastric emptying time, and prevent a steep rise in post-prandial blood glucose levels.

Incretin Mimetics Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Indication (Diabetes, Others), Drugs (Exenatide, Liraglutide, Sitagliptin, Saxagliptin, Alogliptin, Linagliptin, Others), Route of Administration (Oral, parenteral, Others), Application (Solid Tumors, Blood-related Tumor), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Pfizer Inc (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb Company (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Mylan N.V. (U.S.), Novartis AG (Switzerland), Lupin (India), Cipla Inc (India), Fresenius SE & Co. KGaA (Germany), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.)

Market Opportunities

  • Increased Drug Approvals
  • Increasing Demand for Retail Pharmacies

Global Incretin Mimetics Market Dynamics

Drivers

  • Rising Incidence of Diabetes

The adult diabetes population in 2021 was approximately 537 million, and this number will rise to 643 million in 2030. There are several factors such as obesity, unhealthy diet, and physical inactivity because of which the rate of newly diagnosed cases of Type 1 and Type 2 diabetes is seen to increase. Thus, this boosts the market growth.

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most of the products are available in capsule form and tablet form and it is a very feasible route of administration.

Opportunities

  • Technological Development

Several technological developments in the field are constantly improving for the patients' better improvement. Major market players primarily focus on upgrading the drugs, which works as an opportunity for the market to grow. In addition, improving treatment, better equipment for disease detection, and hospital facilities are expected to boost the market demand. Thus, all these factors enhance the market expansion.

  • Increasing Demand for Retail Pharmacies

The rise in the number of renal drugs delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

  • Side Effects of Renal Drugs

The side effects associated with these agents could curb the growth of the global incretin mimetics market over a forecast period. Effects such as vomiting, nausea, pain, and several others, can hamper the market growth.

  • High Cost

The huge expenditure associated with these agents surely hamper the market growth.

This global incretin mimetics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global incretin mimetics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Incretin Mimetics Market  Scope

The global incretin mimetics market is segmented on the basis of indication, drugs, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

  • Diabetes
  • Others

Drugs

  • Exenatide
  • Liraglutide
  • Sitagliptin
  • Saxagliptin
  • Alogliptin
  • Linagliptin
  • Others

Application

  • Solid Tumors
  • Blood-related Tumor

Route of Administration

  • Oral
  • Parenteral
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Incretin Mimetics Market Regional Analysis/Insights

The global incretin mimetics market is analysed and market size insights and trends are provided by indication, drugs, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global incretin mimetics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a highest growth for global incretin mimetics market throughout the forecasted period due to increased government awareness programs and number of generic drugs.

North America dominates the market due to the presence of key manufacture of the product, high research and development, healthcare expenditure, and skilled professionals.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Incretin Mimetics Market Share Analysis

The global incretin mimetics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global incretin mimetics market.

Key players operating in the global incretin mimetics market include:

  • Pfizer Inc (U.S.)
  • AstraZeneca (U.K.)
  • Bristol-Myers Squibb Company (U.S.)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Sun Pharmaceutical Industries Ltd (India)
  • Mylan N.V. (U.S.)
  • Novartis AG (Switzerland)
  • Lupin (India)
  • Cipla Inc (India)
  • Aurobindo Pharma (India)
  • Fresenius SE & Co. KGaA (Germany)
  • Sanofi (France)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Abbott (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The factors such as increased incidence of diabetes and rising demand for oral drugs are acting as the major drivers for the global incretin mimetics market.
Pfizer Inc (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb Company (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Mylan N.V. (U.S.), Novartis AG (Switzerland), Lupin (India), Cipla Inc (India), Fresenius SE & Co. KGaA (Germany), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.).
North America dominates the market due to the presence of key manufacturers of the product, high research and development, healthcare expenditure, and skilled professionals.
Asia-Pacific has been witnessing the highest growth for the global incretin mimetics market throughout the forecasted period due to increased government awareness programs and a number of generic drugs.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials